Industry: Healthcare
Published Date: March-2024
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 225
Report ID: PMRREP2784
1. Executive Summary
1.1. Global Molecular Diagnostics Market Snapshot, 2024 and 2031
1.2. Market Opportunity Assessment, 2024 - 2031, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Molecular Diagnostics Market: Value Chain
2.3.1. List of Manufacturers
2.3.2. List of Distributors
2.3.3. Profitability Analysis
2.4. Macro-Economic Factors
2.4.1. Global Sectorial Outlook
2.4.2. Global GDP Growth Outlook
2.4.3. Global Parent Market Overview
2.5. Forecast Factors - Relevance and Impact
2.6. Covid-19 Impact Assessment
2.7. Technology Advancement
2.8. Disease Epidemiology
2.9. Porter Five Force’s Analysis
2.10. Regulatory Scenario
2.11. Product Adoption Analysis
2.12. Parent Market Analysis
3. Price Trend Analysis, 2024 - 2031
3.1. Key Highlights
3.2. Key Factors Impacting Product Prices
3.3. Prices by Product Type
3.4. Regional Prices and Product Preferences
4. Global Molecular Diagnostics Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
4.1. Key Highlights
4.1.1. Market Volume (Units) Projections, by Product Type
4.1.2. Market Size and Y-o-Y Growth
4.1.3. Absolute $ Opportunity
4.2. Market Size (US$ Mn) Analysis and Forecast
4.2.1. Historical Market Size Analysis, 2019-2023
4.2.2. Current Market Size Forecast, 2024-2031
4.3. Global Molecular Diagnostics Market Outlook: Product Type
4.3.1. Introduction / Key Findings
4.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis by Product Type, 2019 - 2023
4.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast by Product Type, 2024 - 2031
4.3.3.1. Instruments
4.3.3.1.1. Polymerase Chain Reaction (PCR) Systems
4.3.3.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
4.3.3.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
4.3.3.1.4. Microarrays
4.3.3.2. Reagent
4.3.3.2.1. Antibodies
4.3.3.2.2. DNA Template
4.3.3.2.3. DNA Polymerase
4.3.3.2.4. Oligonucleotide Primers
4.3.3.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
4.3.3.2.6. Buffer
4.3.3.3. Assay Kits
4.3.3.4. Consumables
4.4. Market Attractiveness Analysis: Product Type
4.5. Global Molecular Diagnostics Market Outlook: Disease Area
4.5.1. Introduction / Key Findings
4.5.2. Historical Market Size (US$ Mn) Analysis By Disease Area, 2019 - 2023
4.5.3. Current Market Size (US$ Mn) Forecast By Disease Area, 2024 - 2031
4.5.3.1. Infectious Disease
4.5.3.2. Diabetes
4.5.3.3. Cardiology
4.5.3.4. Oncology
4.5.3.5. Nephrology
4.5.3.6. Autoimmune Disease
4.5.3.7. Dermatology
4.5.3.8. Wound Care
4.5.3.9. Others
4.6. Market Attractiveness Analysis: Disease Area
4.7. Global Molecular Diagnostics Market Outlook: End User
4.7.1. Introduction / Key Findings
4.7.2. Historical Market Size (US$ Mn) Analysis by End User, 2019 - 2023
4.7.3. Current Market Size (US$ Mn) Forecast by End User, 2024 - 2031
4.7.3.1. Hospitals & Clinics
4.7.3.2. Diagnostics Laboratories
4.7.3.3. Academic and Research Institutes
4.7.3.4. Biopharmaceutical Companies
4.8. Market Attractiveness Analysis: End User
5. Global Molecular Diagnostics Market Outlook: Region
5.1. Key Highlights
5.2. Historical Market Size (US$ Mn) Analysis by Region, 2019 - 2023
5.3. Current Market Size (US$ Mn) Forecast by Region, 2024 - 2031
5.3.1. North America
5.3.2. Europe
5.3.3. East Asia
5.3.4. South Asia and Oceania
5.3.5. Latin America
5.3.6. Middle East & Africa
5.4. Market Attractiveness Analysis: Region
6. North America Molecular Diagnostics Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
6.1. Key Highlights
6.2. Historical Market Size (US$ Mn) Analysis by Market, 2019 - 2023
6.2.1. by Country
6.2.2. by Product Type
6.2.3. By Disease Area
6.2.4. by End User
6.3. Current Market Size (US$ Mn) Forecast by Country, 2024 - 2031
6.3.1. U.S.
6.3.2. Canada
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast by Product Type, 2024 - 2031
6.4.1. Instruments
6.4.1.1. Polymerase Chain Reaction (PCR) Systems
6.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
6.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
6.4.1.4. Microarrays
6.4.2. Reagent
6.4.2.1. Antibodies
6.4.2.2. DNA Template
6.4.2.3. DNA Polymerase
6.4.2.4. Oligonucleotide Primers
6.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
6.4.2.6. Buffer
6.4.3. Assay Kits
6.4.4. Consumables
6.5. Current Market Size (US$ Mn) Forecast By Disease Area, 2024 - 2031
6.5.1. Infectious Disease
6.5.2. Diabetes
6.5.3. Cardiology
6.5.4. Oncology
6.5.5. Nephrology
6.5.6. Autoimmune Disease
6.5.7. Dermatology
6.5.8. Wound Care
6.5.9. Others
6.6. Current Market Size (US$ Mn) Forecast by End User, 2024 - 2031
6.6.1. Hospitals & Clinics
6.6.2. Diagnostics Laboratories
6.6.3. Academic and Research Institutes
6.6.4. Biopharmaceutical Companies
6.7. Market Attractiveness Analysis
7. Europe Molecular Diagnostics Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
7.1. Key Highlights
7.2. Historical Market Size (US$ Mn) Analysis by Market, 2019 - 2023
7.2.1. by Country
7.2.2. by Product Type
7.2.3. By Disease Area
7.2.4. by End User
7.3. Current Market Size (US$ Mn) Forecast by Country, 2024 - 2031
7.3.1. Germany
7.3.2. France
7.3.3. U.K.
7.3.4. Italy
7.3.5. Spain
7.3.6. Russia
7.3.7. Türkiye
7.3.8. Rest of Europe
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast by Product Type, 2024 - 2031
7.4.1. Instruments
7.4.1.1. Polymerase Chain Reaction (PCR) Systems
7.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
7.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
7.4.1.4. Microarrays
7.4.2. Reagent
7.4.2.1. Antibodies
7.4.2.2. DNA Template
7.4.2.3. DNA Polymerase
7.4.2.4. Oligonucleotide Primers
7.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
7.4.2.6. Buffer
7.4.3. Assay Kits
7.4.4. Consumables
7.5. Current Market Size (US$ Mn) Forecast By Disease Area, 2024 - 2031
7.5.1. Infectious Disease
7.5.2. Diabetes
7.5.3. Cardiology
7.5.4. Oncology
7.5.5. Nephrology
7.5.6. Autoimmune Disease
7.5.7. Dermatology
7.5.8. Wound Care
7.5.9. Others
7.6. Current Market Size (US$ Mn) Forecast by End User, 2024 - 2031
7.6.1. Hospitals & Clinics
7.6.2. Diagnostics Laboratories
7.6.3. Academic and Research Institutes
7.6.4. Biopharmaceutical Companies
7.7. Market Attractiveness Analysis
8. East Asia Molecular Diagnostics Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
8.1. Key Highlights
8.2. Historical Market Size (US$ Mn) Analysis by Market, 2019 - 2023
8.2.1. by Country
8.2.2. by Product Type
8.2.3. By Disease Area
8.2.4. by End User
8.3. Current Market Size (US$ Mn) Forecast by Country, 2024 - 2031
8.3.1. China
8.3.2. Japan
8.3.3. South Korea
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast by Product Type, 2024 - 2031
8.4.1. Instruments
8.4.1.1. Polymerase Chain Reaction (PCR) Systems
8.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
8.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
8.4.1.4. Microarrays
8.4.2. Reagent
8.4.2.1. Antibodies
8.4.2.2. DNA Template
8.4.2.3. DNA Polymerase
8.4.2.4. Oligonucleotide Primers
8.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
8.4.2.6. Buffer
8.4.3. Assay Kits
8.4.4. Consumables
8.5. Current Market Size (US$ Mn) Forecast By Disease Area, 2024 - 2031
8.5.1. Infectious Disease
8.5.2. Diabetes
8.5.3. Cardiology
8.5.4. Oncology
8.5.5. Nephrology
8.5.6. Autoimmune Disease
8.5.7. Dermatology
8.5.8. Wound Care
8.5.9. Others
8.6. Current Market Size (US$ Mn) Forecast by End User, 2024 - 2031
8.6.1. Hospitals & Clinics
8.6.2. Diagnostics Laboratories
8.6.3. Academic and Research Institutes
8.6.4. Biopharmaceutical Companies
8.7. Market Attractiveness Analysis
9. South Asia & Oceania Molecular Diagnostics Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
9.1. Key Highlights
9.2. Historical Market Size (US$ Mn) Analysis by Market, 2019 - 2023
9.2.1. by Country
9.2.2. by Product Type
9.2.3. By Disease Area
9.2.4. by End User
9.3. Current Market Size (US$ Mn) Forecast by Country, 2024 - 2031
9.3.1. India
9.3.2. Southeast Asia
9.3.3. ANZ
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast by Product Type, 2024 - 2031
9.4.1. Instruments
9.4.1.1. Polymerase Chain Reaction (PCR) Systems
9.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
9.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
9.4.1.4. Microarrays
9.4.2. Reagent
9.4.2.1. Antibodies
9.4.2.2. DNA Template
9.4.2.3. DNA Polymerase
9.4.2.4. Oligonucleotide Primers
9.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
9.4.2.6. Buffer
9.4.3. Assay Kits
9.4.4. Consumables
9.5. Current Market Size (US$ Mn) Forecast By Disease Area, 2024 - 2031
9.5.1. Infectious Disease
9.5.2. Diabetes
9.5.3. Cardiology
9.5.4. Oncology
9.5.5. Nephrology
9.5.6. Autoimmune Disease
9.5.7. Dermatology
9.5.8. Wound Care
9.5.9. Others
9.6. Current Market Size (US$ Mn) Forecast by End User, 2024 - 2031
9.6.1. Hospitals & Clinics
9.6.2. Diagnostics Laboratories
9.6.3. Academic and Research Institutes
9.6.4. Biopharmaceutical Companies
9.7. Market Attractiveness Analysis
10. Latin America Molecular Diagnostics Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
10.1. Key Highlights
10.2. Historical Market Size (US$ Mn) Analysis by Market, 2019 - 2023
10.2.1. by Country
10.2.2. by Product Type
10.2.3. By Disease Area
10.2.4. by End User
10.3. Current Market Size (US$ Mn) Forecast by Country, 2024 - 2031
10.3.1. Brazil
10.3.2. Mexico
10.3.3. Rest of Latin America
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast by Product Type, 2024 - 2031
10.4.1. Instruments
10.4.1.1. Polymerase Chain Reaction (PCR) Systems
10.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
10.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
10.4.1.4. Microarrays
10.4.2. Reagent
10.4.2.1. Antibodies
10.4.2.2. DNA Template
10.4.2.3. DNA Polymerase
10.4.2.4. Oligonucleotide Primers
10.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
10.4.2.6. Buffer
10.4.3. Assay Kits
10.4.4. Consumables
10.5. Current Market Size (US$ Mn) Forecast By Disease Area, 2024 - 2031
10.5.1. Infectious Disease
10.5.2. Diabetes
10.5.3. Cardiology
10.5.4. Oncology
10.5.5. Nephrology
10.5.6. Autoimmune Disease
10.5.7. Dermatology
10.5.8. Wound Care
10.5.9. Others
10.6. Current Market Size (US$ Mn) Forecast by End User, 2024 - 2031
10.6.1. Hospitals & Clinics
10.6.2. Diagnostics Laboratories
10.6.3. Academic and Research Institutes
10.6.4. Biopharmaceutical Companies
10.7. Market Attractiveness Analysis
11. Middle East & Africa Molecular Diagnostics Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
11.1. Key Highlights
11.2. Historical Market Size (US$ Mn) Analysis by Market, 2019 - 2023
11.2.1. by Country
11.2.2. by Product Type
11.2.3. By Disease Area
11.2.4. by End User
11.3. Current Market Size (US$ Mn) Forecast by Country, 2024 - 2031
11.3.1. GCC Countries
11.3.2. Egypt
11.3.3. South Africa
11.3.4. Rest of Middle East & Africa
11.4. Current Market Size (US$ Mn) and Volume (Units) Forecast by Product Type, 2024 - 2031
11.4.1. Instruments
11.4.1.1. Polymerase Chain Reaction (PCR) Systems
11.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
11.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
11.4.1.4. Microarrays
11.4.2. Reagent
11.4.2.1. Antibodies
11.4.2.2. DNA Template
11.4.2.3. DNA Polymerase
11.4.2.4. Oligonucleotide Primers
11.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
11.4.2.6. Buffer
11.4.3. Assay Kits
11.4.4. Consumables
11.5. Current Market Size (US$ Mn) Forecast By Disease Area, 2024 - 2031
11.5.1. Infectious Disease
11.5.2. Diabetes
11.5.3. Cardiology
11.5.4. Oncology
11.5.5. Nephrology
11.5.6. Autoimmune Disease
11.5.7. Dermatology
11.5.8. Wound Care
11.5.9. Others
11.6. Current Market Size (US$ Mn) Forecast by End User, 2024 - 2031
11.6.1. Hospitals & Clinics
11.6.2. Diagnostics Laboratories
11.6.3. Academic and Research Institutes
11.6.4. Biopharmaceutical Companies
11.7. Market Attractiveness Analysis
12. Competition Landscape
12.1. Market Share Analysis, 2022
12.2. Market Structure
12.2.1. Competition Intensity Mapping by Market
12.2.2. Competition Dashboard
12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
12.3.1. Becton, Dickinson and Company
12.3.1.1. Overview
12.3.1.2. Segments and Products
12.3.1.3. Key Financials
12.3.1.4. Market Developments
12.3.1.5. Market Strategy
12.3.2. Bio-Rad Laboratories Inc
12.3.2.1. Overview
12.3.2.2. Segments and Products
12.3.2.3. Key Financials
12.3.2.4. Market Developments
12.3.2.5. Market Strategy
12.3.3. Thermo Fisher Scientific Inc.
12.3.3.1. Overview
12.3.3.2. Segments and Products
12.3.3.3. Key Financials
12.3.3.4. Market Developments
12.3.3.5. Market Strategy
12.3.4. Merck KGaA
12.3.4.1. Overview
12.3.4.2. Segments and Products
12.3.4.3. Key Financials
12.3.4.4. Market Developments
12.3.4.5. Market Strategy
12.3.5. Agilent Technologies, Inc.
12.3.5.1. Overview
12.3.5.2. Segments and Products
12.3.5.3. Key Financials
12.3.5.4. Market Developments
12.3.5.5. Market Strategy
12.3.6. Hoffmann la roche
12.3.6.1. Overview
12.3.6.2. Segments and Products
12.3.6.3. Key Financials
12.3.6.4. Market Developments
12.3.6.5. Market Strategy
12.3.7. Qiagen N.V.
12.3.7.1. Overview
12.3.7.2. Segments and Products
12.3.7.3. Key Financials
12.3.7.4. Market Developments
12.3.7.5. Market Strategy
12.3.8. Illumina, Inc.
12.3.8.1. Overview
12.3.8.2. Segments and Products
12.3.8.3. Key Financials
12.3.8.4. Market Developments
12.3.8.5. Market Strategy
12.3.9. DiaSorin S.p.A
12.3.9.1. Overview
12.3.9.2. Segments and Products
12.3.9.3. Key Financials
12.3.9.4. Market Developments
12.3.9.5. Market Strategy
12.3.10. Hologic Inc.
12.3.10.1. Overview
12.3.10.2. Segments and Products
12.3.10.3. Key Financials
12.3.10.4. Market Developments
12.3.10.5. Market Strategy
12.3.11. Siemens Healthineers AG
12.3.11.1. Overview
12.3.11.2. Segments and Products
12.3.11.3. Key Financials
12.3.11.4. Market Developments
12.3.11.5. Market Strategy
12.3.12. Seegene, Inc.
12.3.12.1. Overview
12.3.12.2. Segments and Products
12.3.12.3. Key Financials
12.3.12.4. Market Developments
12.3.12.5. Market Strategy
12.3.13. Grifols, S.A.
12.3.13.1. Overview
12.3.13.2. Segments and Products
12.3.13.3. Key Financials
12.3.13.4. Market Developments
12.3.13.5. Market Strategy
12.3.14. bioMérieux
12.3.14.1. Overview
12.3.14.2. Segments and Products
12.3.14.3. Key Financials
12.3.14.4. Market Developments
12.3.14.5. Market Strategy
12.3.15. QuidelOrtho Corporation
12.3.15.1. Overview
12.3.15.2. Segments and Products
12.3.15.3. Key Financials
12.3.15.4. Market Developments
12.3.15.5. Market Strategy
12.3.16. RapidBio
12.3.16.1. Overview
12.3.16.2. Segments and Products
12.3.16.3. Key Financials
12.3.16.4. Market Developments
12.3.16.5. Market Strategy
12.3.17. Abbott Laboratories
12.3.17.1. Overview
12.3.17.2. Segments and Products
12.3.17.3. Key Financials
12.3.17.4. Market Developments
12.3.17.5. Market Strategy
12.3.18. Danaher Corporation
12.3.18.1. Overview
12.3.18.2. Segments and Products
12.3.18.3. Key Financials
12.3.18.4. Market Developments
12.3.18.5. Market Strategy
13. Appendix
13.1. Research Methodology
13.2. Research Assumptions
13.3. Acronyms and Abbreviations
